Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Peter Marks
Peter Marks
'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns
Fierce Biotech
Wed, 04/3/24 - 10:30 pm
Peter Marks
FDA
cancer vaccine
Moderna Therapeutics
Merck
MRNA
mRNA-4157
FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma
Medical Marketing and Media
Fri, 02/16/24 - 11:42 am
CAR-T
FDA
Peter Marks
CBER
FDA’s Marks Advocates for Flexibility in Rare Disease Gene Therapy Trials
BioSpace
Mon, 01/22/24 - 11:01 am
FDA
regulatory
Peter Marks
CBER
clinical trials
gene therapy
FDA’s OTP Super Office on Track to Fill 500 Positions
BioSpace
Thu, 08/10/23 - 09:59 am
FDA
OTP
CBER
Peter Marks
FDA CBER Chief Marks overrules staff drug reviewers 'with trepidation'
Fierce Biotech
Sat, 07/29/23 - 10:50 pm
FDA
Peter Marks
CBER
drug reviews
'Like salmon swimming upstream': FDA's Peter Marks lays out plan to boost gene therapy approvals
Fierce Biotech
Wed, 04/5/23 - 07:13 pm
FDA
gene therapy
Peter Marks
FDA's Peter Marks backs accelerated approval for gene therapies
BioSpace
Tue, 03/21/23 - 11:36 am
FDA
CDER
Peter Marks
gene therapy
accelerated approval
CBER director Peter Marks says FDA is growing to keep up with cell and gene therapies
Endpoints
Wed, 03/1/23 - 06:50 pm
CBER
Peter Marks
FDA
gene therapy
cell therapy
Can FDA replicate Operation Warp Speed for rare diseases? Not yet, but Peter Marks has some ideas
Fierce Biotech
Wed, 05/11/22 - 10:29 am
FDA
Peter Marks
CBER
gene therapy
cell therapy
Operation Warp Speed
Rare Diseases
FDA's Peter Marks to Congress: Youngest kids vaccine won't need to hit 50% efficacy mark
Endpoints
Mon, 05/9/22 - 10:09 am
FDA
congress
Peter Marks
vaccines
COVID-19
pediatric
FDA's top vaccine leader explains why Covid-19 'boosters' may really just be the 3rd shot in the primary series
Endpoints
Thu, 09/30/21 - 10:51 am
FDA
Peter Marks
physicians
COVID-19
vaccines
boosters
FDA's Marks takes over vaccines office as agency prepares to part ways with 2 key officials
Fierce Pharma
Tue, 09/28/21 - 11:11 am
FDA
CBER
Peter Marks
vaccines
COVID-19